| |
Patients <18 years N (%) |
Patients ≥ 18 years N (%) |
Total patients N (%) |
| First intake of grass AIT |
797 |
964 |
1,761 |
| Follow-up information available |
711 (89.2) |
801 (83.1) |
1,512 (85.9) |
| At least 1 Follow-up visit |
693 (87.0) |
784 (81.3) |
1,477 (83.9) |
| Seasonal or post-seasonal visit |
652 (81.8) |
729 (75.6) |
1,381 (78.4) |
| Premature study termination due to |
|
|
|
| Adverse events |
72 (9.0) |
71 (7.4) |
143 (8.1) |
| Contraindication, intercurrent disease |
4 (0.5) |
2 (0.2) |
6 (0.3) |
| Pregnancy, wish to have a child |
- |
8 (0.8) |
8 (0.5) |
| Wish of patient / parents; patient refused administration |
19 (2.4) |
8 (0.8) |
27 (1.5) |
| Change-over to another drug |
8 (1.0) |
13 (1.3) |
21 (1.2) |
| Other reasons |
7 (0.9) |
21 (2.2) |
28 (1.6) |
| Lacking compliance |
76 (9.5) |
171 (17.7) |
247 (14.0) |
| Unknown (no information available) |
45 (5.6) |
86 (8.9) |
131 (7.4) |
| Treatment continued after end of study |
566 (71.0) |
584 (60.6) |
1,150 (65.3) |
